Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07563933Not yet recruiting
Randomised, open-label trial of ampicillin + sulbactam and amoxicillin + clavulanate in acute appendicitis (2 arms), sponsored by Ministry of Health and Population. Primary endpoints: Rate of Surgical Site Infection at 30 days, Rate of Intra-abdominal Abscess at 30 days and 1 more. Planned start May 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07563933.